Citigroup Inc Acrivon Therapeutics, Inc. Transaction History

Citigroup Inc

  • $169 Billion
  • Q3 2024

A detailed history of Citigroup Inc transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 11,216 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,216
Previous 5,082 120.7%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
N/A
6,134 Added 120.7%
11,216 $0
Q2 2024

Aug 12, 2024
BUY
N/A
546 Added 12.04%
5,082 $0
Q1 2024

May 10, 2024
BUY
N/A
2,489 Added 121.59%
4,536 $0
Q4 2023

Feb 09, 2024
BUY
N/A
1,817 Added 790.0%
2,047 $0
Q3 2023

Nov 09, 2023
SELL
N/A
-2,560 Reduced 91.76%
230 $0
Q2 2023

Aug 10, 2023
BUY
N/A
2,588 Added 1281.19%
2,790 $0
Q1 2023

May 11, 2023
BUY
N/A
202 New
202 $0

Others Institutions Holding ACRV

# of Institutions
53
Shares Held
23.2M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email